← Leaderboards
Jennifer Bailey Lundberg
Johns Hopkins University
$1,232,132
Attributed
$2,412,937
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $676.1K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,412,937 · 3
By mechanism
R01$1,948,805 · 1
R21$412,806 · 1
F32$51,326 · 1
Top collaborators
- Nirav Thosani3 shared
- Haoqiang Ying2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elia J Duh$12,153,743
- Maurice J Bessman$2,289,088
- Henry R Halperin$35,491,139
- Zsolt Szabo$5,838,051
- David Sidransky$59,922,938
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseDiagnosisIn VivoProgramsTumorCellsLifeMalignant NeoplasmsFutureTargeted TreatmentUnited States National Institutes Of HealthMissionPatient-Focused OutcomesPublic Health RelevanceAdenocarcinomaIncidencePublishingMediatingMalignant Neoplasm Of PancreasAdenosineAnimal ModelClinical TrialsClinical CareAbscopal Effect
Grant awards (6)
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer$651,173
R01 · FY2025 · CA
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer$621,551
R01 · FY2024 · CA
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer$676,081
R01 · FY2023 · CA · contact PI
Defining the role of Mst1/Mst2 in regulating metabolic alterations in Ras driven NSCLC$179,791
R21 · FY2022 · CA · contact PI
Defining the role of Mst1/Mst2 in regulating metabolic alterations in Ras driven NSCLC$233,015
R21 · FY2021 · CA · contact PI
Stopping the Start: Understanding PanIN Initiation and Progression$51,326
F32 · FY2011 · CA · contact PI